Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 2101 AL 2115

The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses

Jan A, Gonçalves NP, Vaegter CB, Jensen PH, Ferreira N.

Int J Mol Sci. 2021 Aug 3;22(15):8338. doi: 10.3390/ijms22158338.

Traditional application and modern pharmacological research of Eucommia ulmoides Oliv

Huang L, Lyu Q, Zheng W, Yang Q, Cao G.

Chin Med. 2021 Aug 6;16(1):73. doi: 10.1186/s13020-021-00482-7.

Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?

van Wamelen DJ, Sringean J, Trivedi D, Carroll CB, Schrag AE, Odin P, Antonini A, Bloem BR, Bhidayasiri R, Chaudhuri KR; International Parkinson and Movement Disorder Society Non Motor Parkinson's Disease Study Group.

Parkinsonism Relat Disord. 2021 Aug;89:186-194. doi: 10.1016/j.parkreldis.2021.07.032. Epub 2021 Jul 31.

On-Demand Therapy for OFF Episodes in Parkinson's Disease

Olanow CW, Poewe W, Rascol O, Stocchi F.

Mov Disord. 2021 Oct;36(10):2244-2253. doi: 10.1002/mds.28726. Epub 2021 Aug 7.

Effectiveness of a Long-Term, Home-Based Aerobic Exercise Intervention on Slowing the Progression of Parkinson Disease: Design of the Cyclical Lower Extremity Exercise for Parkinson Disease II (CYCLE-II) Study

Alberts JL, Rosenfeldt AB, Lopez-Lennon C, Suttman E, Jansen AE, Imrey PB, Dibble LE.

Phys Ther. 2021 Nov 1;101(11):pzab191. doi: 10.1093/ptj/pzab191.

Rapidly progressive dementia and Parkinsonism as the first symptoms of dural arteriovenous fistula. The Sapienza University experience and comprehensive literature review concerning the clinical course of 102 patients

Armocida D, Palmieri M, Paglia F, Berra LV, D'Angelo L, Frati A, Santoro A.

Clin Neurol Neurosurg. 2021 Sep;208:106835. doi: 10.1016/j.clineuro.2021.106835. Epub 2021 Jul 22.

The importance of assessing interactions between different circuits in primary motor cortex in Parkinson's disease

Guerra A, Belvisi D, Berardelli A.

Clin Neurophysiol. 2021 Oct;132(10):2668-2670. doi: 10.1016/j.clinph.2021.07.010. Epub 2021 Jul 24.

Neurogenic and anti-inflammatory effects of probiotics in Parkinson's disease: A systematic review of preclinical and clinical evidence

Leta V, Ray Chaudhuri K, Milner O, Chung-Faye G, Metta V, Pariante CM, Borsini A.

Brain Behav Immun. 2021 Nov;98:59-73. doi: 10.1016/j.bbi.2021.07.026. Epub 2021 Aug 5.

Homozygous PLA2G6 (PARK 14) gene mutation associated neuropsychiatric phenotypes from southern India

Sakhardande KA, Reddi VSK, Mishra S, Navin K, Ramu A, Arunachal G, Mangalore S, Yadav R, Jain S.

Parkinsonism Relat Disord. 2021 Sep;90:49-51. doi: 10.1016/j.parkreldis.2021.07.026. Epub 2021 Jul 28.

Next-Generation Gene Therapy for Parkinson's Disease Using Engineered Viral Vectors

Björklund T, Davidsson M.

J Parkinsons Dis. 2021;11(s2):S209-S217. doi: 10.3233/JPD-212674.

Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity

Snyder A, Gruber-Baldini AL, Rainer von Coelln F, Savitt JM, Reich SG, Armstrong MJ, Shulman LM.

J Parkinsons Dis. 2021;11(4):1995-2003. doi: 10.3233/JPD-212705.

Improved Delivery Methods for Gene Therapy and Cell Transplantation in Parkinson's Disease

Larson PS.

J Parkinsons Dis. 2021;11(s2):S199-S206. doi: 10.3233/JPD-212710.

An Update on Gene Therapy Approaches for Parkinson's Disease: Restoration of Dopaminergic Function

Van Laar AD, Van Laar VS, San Sebastian W, Merola A, Elder JB, Lonser RR, Bankiewicz KS.

J Parkinsons Dis. 2021;11(s2):S173-S182. doi: 10.3233/JPD-212724.

Effectiveness of Long-Term Physiotherapy in Parkinson's Disease: A Systematic Review and Meta-Analysis

Okada Y, Ohtsuka H, Kamata N, Yamamoto S, Sawada M, Nakamura J, Okamoto M, Narita M, Nikaido Y, Urakami H, Kawasaki T, Morioka S, Shomoto K, Hattori N.

J Parkinsons Dis. 2021;11(4):1619-1630. doi: 10.3233/JPD-212782.

Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains Stable Levodopa and Carbidopa Exposure Following Subcutaneous Infusion

Rosebraugh M, Liu W, Neenan M, Facheris MF.

J Parkinsons Dis. 2021;11(4):1695-1702. doi: 10.3233/JPD-212813.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias